Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Le Xiong

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Journal of Oncology|November 28, 2022
Circular RNA circ_0004488 Increases Cervical Cancer Paclitaxel Resistance via the miR-136/MEX3C Signaling PathwayHanjie Yi, Yongqing Han, Qin Li, et al.
Central-European Journal of Immunology|October 13, 2025
Comparative analysis of PD-L1 expression and tumor-infiltrating lymphocytes between primary breast cancer and matched metastatic lesions: implications for immunotherapyDaolin Zeng, Qin Li, Xia Wang, et al.
Clinical and Experimental Medicine|February 2, 2026
Novel antagonist APG-115 targets MDM2-p53 to induce p53-mediated apoptosis and radiosensitization in colorectal cancerHanJie Yi, YongQing Han, Xia Wang, et al.
Journal of Agricultural and Food Chemistry|September 3, 2016
Structure-Dependent Membrane-Perturbing Potency of Four Proanthocyanidin Dimers on 3T3-L1 PreadipocytesWei Zhu, Le Xiong, Jinming Peng, et al.
Nanotheranostics|January 18, 2021
Resveratrol and its Nanoparticle suppress Doxorubicin/Docetaxel-resistant anaplastic Thyroid Cancer Cells <i>in vitro</i> and <i>in vivo</i>Le Xiong, Xiao-Min Lin, Jun-Hua Nie, et al.
Scientific Reports|November 23, 2016
Molecular Insight into Affinities of Gallated and Nongallated Proanthocyanidins Dimers to Lipid BilayersWei Zhu, Le Xiong, Jinming Peng, et al.
BMC Cancer|April 13, 2017
Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patientsLe Xiong, Xiao-Li Zeng, Chang-Kuo Guo, et al.
Translational Oncology|June 25, 2026
The ESR1-MYH14 axis functions as a critical driver of cervical cancer progression and metastasisHanjie Yi, Shanfeng Li, Yongqing Han, et al.
Journal of Translational Medicine|March 15, 2022
Potential benefit of osismertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancerYali Yi, Jing Cai, Peng Xu, et al.
Biochemical and Biophysical Research Communications|March 14, 2017
USP39, a direct target of microRNA-133a, promotes progression of pancreatic cancer via the AKT pathwayJing Cai, Tiande Liu, Peng Huang, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Journal of Oncology|November 28, 2022
Circular RNA circ_0004488 Increases Cervical Cancer Paclitaxel Resistance via the miR-136/MEX3C Signaling PathwayHanjie Yi, Yongqing Han, Qin Li, et al.
Central-European Journal of Immunology|October 13, 2025
Comparative analysis of PD-L1 expression and tumor-infiltrating lymphocytes between primary breast cancer and matched metastatic lesions: implications for immunotherapyDaolin Zeng, Qin Li, Xia Wang, et al.
Clinical and Experimental Medicine|February 2, 2026
Novel antagonist APG-115 targets MDM2-p53 to induce p53-mediated apoptosis and radiosensitization in colorectal cancerHanJie Yi, YongQing Han, Xia Wang, et al.
Journal of Agricultural and Food Chemistry|September 3, 2016
Structure-Dependent Membrane-Perturbing Potency of Four Proanthocyanidin Dimers on 3T3-L1 PreadipocytesWei Zhu, Le Xiong, Jinming Peng, et al.
Nanotheranostics|January 18, 2021
Resveratrol and its Nanoparticle suppress Doxorubicin/Docetaxel-resistant anaplastic Thyroid Cancer Cells <i>in vitro</i> and <i>in vivo</i>Le Xiong, Xiao-Min Lin, Jun-Hua Nie, et al.
Scientific Reports|November 23, 2016
Molecular Insight into Affinities of Gallated and Nongallated Proanthocyanidins Dimers to Lipid BilayersWei Zhu, Le Xiong, Jinming Peng, et al.
BMC Cancer|April 13, 2017
Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patientsLe Xiong, Xiao-Li Zeng, Chang-Kuo Guo, et al.
Translational Oncology|June 25, 2026
The ESR1-MYH14 axis functions as a critical driver of cervical cancer progression and metastasisHanjie Yi, Shanfeng Li, Yongqing Han, et al.
Journal of Translational Medicine|March 15, 2022
Potential benefit of osismertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancerYali Yi, Jing Cai, Peng Xu, et al.
Biochemical and Biophysical Research Communications|March 14, 2017
USP39, a direct target of microRNA-133a, promotes progression of pancreatic cancer via the AKT pathwayJing Cai, Tiande Liu, Peng Huang, et al.
Pageof 6